| FRIDAY MARCH 24, 2023 | HALL A | |
 | |
| 12:15–13:15 | Roche Industry Sponsored Luncheon Symposium: Advancing the management of nAMD via Ang-2/VEGF-A dual inhibition (Lunch boxes served 12:00–12:15) |
| Chair: | Ângela Carneiro, Portugal |
| 12:15 | Welcome and opening remarks Ângela Carneiro, Portugal |
| 12:20 | Evidence for Ang-2/VEGF-A inhibition in nAMD: Preclinical and Phase 3 data Rufino Silva, Portugal |
| 12:35 | Real-world clinical case discussions James Talks, UK David Almeida, USA Audience Q&A with the panel |
| 13:10 | Closing remarks Ângela Carneiro, Portugal |
